Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1116_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Acknowledgments by Salman Al-Sabah
- •Contents
- •Editors and Contributors
- •Introduction
- •Learning About the Laparoscopic Sleeve Gastrectomy (lSG) The Birth and Evolution of Laparoscopic Sleeve Gastrectomy
- •1 Introduction
- •2 Costing Methods
- •3 Costing Components
- •4 Cost of Obesity and Overweight: The Evidence
- •5 Overall Cost of Obesity
- •6.1 Ischaemic Heart Disease and Stroke
- •References
- •Obesity, a Costly Epidemic
- •6.2 Diabetes Mellitus
- •6.3 Osteoarthritis
- •6.4 Cancers
- •7 Conclusion
- •References
- •The Health Effects of Obesity
- •1 Obesity Reduces Life Expectancy
- •2 Obesity and Cardiovascular Disease
- •3 Obesity and Respiratory Disease
- •4 Obesity and Cancer
- •5 Other Obesity-Related Conditions
- •6 Health Effects of Obesity in Special Populations
- •6.1 Transplant Recipients
- •6.2 Orthopedic Surgery Patients
- •6.3 Pregnancy
- •6.4 Children and Adolescents
- •7 Conclusion
- •References
- •Obesity and Body Mass Index
- •2 Obesity and BMI
- •3 Percent Excess Weight Loss (%EWL)
- •4 Percent Excess BMI loss (%EBMIL)
- •5 Percent of Total Weight Loss (%TWL)
- •References
- •Dealing with Obesity: Patient Perspective
- •1 Considering the Psychology of Obesity
- •2 Education for Success
- •3 Understanding the Necessity of Mind Shift for Success
- •The Future of Bariatric Surgery and Genetics
- •1 Heritability and Obesity
- •2 Weight Loss Interventions and Genetics
- •3 Bariatric Surgery and Genetics
- •References
- •Sleeve Gastrectomy Registries
- •1 Introduction
- •3 The Value of Registries
- •7.1 Direct-Data Entry Only
- •7.2 Electronic Upload Only
- •8 Key Step 5—Create a Suitable Minimum Dataset
- •9 Key Step 6—Layer in GDPR Compliance
- •14 Conclusion
- •References
- •Weight Loss: Diet Options
- •1 Introduction
- •2 Principles in Dietary Therapies
- •3 Diet Options for Weight Loss
- •4 The Weight-Maintenance Diet
- •5 Summary
- •References
- •Candidates for Sleeve Gastrectomy
- •Eligibility Criteria for Sleeve Gastrectomy
- •1 Introduction
- •2 Current Eligibility Criteria for Bariatric Surgery
- •3 Age
- •4 BMI
- •5 Procedure Selection
- •6 Other Considerations in Decision-Making
- •7 Summary
- •References
- •The Sleeve and Pregnancy
- •1 Pre-pregnancy Weight Management
- •2 Pre-pregnancy Supplementation
- •3 Acceptable Weight Changes in Pregnancy
- •4 Care During Pregnancy
- •5 Gestational Diabetes
- •5.1 Screening
- •5.2 Treatment
- •5.3 Mode of Delivery
- •5.4 Postpartum
- •References
- •The Sleeve and Reproductive Potential
- •1 Introduction
- •2 Obesity and Female Reproduction
- •3 Obesity and Male Reproduction
- •4 Female Reproduction Following Bariatric Surgery
- •5 Male Reproduction Following Bariatric Surgery
- •6 Timing of Conception Following Bariatric Surgery
- •8 Conclusion
- •References
- •6 RYGB to SG
- •7 SG After Endoscopic Procedures
- •8 Conclusion
- •References
- •Converting Endoscopic Bariatric Procedures to LSG: POSE, Endosleeve, and Balloon
- •1 Introduction
- •The Sleeve as a Revisional Procedure
- •1 Introduction
- •2 General Considerations
- •3 Choice of Technique Based on Evidence
- •5 Sleeve Gastrectomy to Re-sleeve
- •2 The POSE Procedure
- •2.1 How the POSE is Performed
- •2.2 Converting a POSE to an LSG
- •3 The Endosleeve
- •3.1 How the Endosleeve is Performed
- •3.2 Converting Endosleeve to LSG
- •4 The Balloon
- •4.1 LSG Following Balloon Removal
- •5 Conclusion
- •References
- •The Sleeve Gastrectomy in Adolescents
- •1 Introduction
- •2 Eligibility
- •2.1 Who is Eligible?
- •3 Which Procedure is Right for Adolescents
- •4 Pre- and Post-operative Nutritional Care
- •5 Psychological Concern
- •6 The Outcomes of SG
- •References
- •2 Epidemiology
- •3 Risk Factors
- •4 Pathophysiology
- •5 Clinical Presentation
- •6 Diagnosis
- •7 Non-invasive Tests
- •7.1 Laboratory Investigations
- •7.2 Imaging
- •8 Scoring Systems
- •8.1 Invasive Measure
- •8.1.1 Liver Biopsy
- •9 Clinical Scores
- •10 Sleeve Gastrectomy in NAFLD and NASH
- •13 Sleeve Gastrectomy Pre-transplant
- •15 Sleeve Gastrectomy After Liver Transplantation
- •References
- •Sleeve Gastrectomy in Immunocompromised Patients
- •1 Introduction
- •2 Safety and Postoperative Morbidity
- •2.2 Perioperative Timing of Immunosuppressive Therapy
- •3 Outcomes of SG in Immunocomromised Patients
- •3.2 Changes to Rheumatoid and Autoimmune Conditions
- •4 Summary
- •References
- •Sleeve Gastrectomy and Cancer
- •1 Obesity and Cancer
- •2 Pathogenesis of Cancer in the Obese
- •3 Current Literature
- •4 Bariatric Surgery and Cancer Risk
- •5 Colorectal Cancer (CRC)
- •6 CRC in RYGB Versus SG and AGB
- •7 Breast and Endometrial Cancers
- •8 SG and Gastro-esophageal Cancer
- •9 Conclusion
- •References
- •Multidisciplinary Care Before and After Sleeve Gastrectomy
- •1 Introduction
- •2 Bariatric/Obesity Specialist
- •3 Bariatric Dietitian
- •4 Bariatric Clinical Psychologist
- •5 Bariatric Coordinator
- •6 Conclusion
- •References
- •Psychiatric Evaluation: Pre and Post Sleeve
- •1 Introduction
- •3 Depression
- •4 Eating Disorders
- •5 Anxiety
- •6 Substance Use Disorders
- •7 Self-harm and Suicidal Ideation
- •8 Psychotropic Medications
- •10 Mental Health Preoperative Assessment
- •11 Outline of Domains of the Evaluation
- •12 Psychiatric Contraindications for Bariatric Surgery
- •13 Conducting the Assessment
- •13.1 History of Weight Loss and Previous Attempts
- •13.2 Medical History
- •13.3 Pathological Eating Behavior
- •13.4 Psychiatric History and Screening of Substance Use
- •13.5 Support System
- •13.6 Psychiatric Medication
- •14 Psychiatric Assessment Conclusion
- •15 Special Populations
- •15.1 The Adolescent Patient
- •15.2 Limited Cognitive Function
- •16 The Impact of Bariatric Surgery on Mental Health
- •16.1 Quality of Life
- •16.2 Mental health status
- •16.3 Suicide
- •16.4 Addiction
- •16.5 Eating Disorders
- •16.6 Psychotropic Medication
- •16.7 Postoperative Pharmacological Considerations
- •17 Conclusion
- •References
- •Insurance, Self-Pay and Medical Tourism
- •How Much Does the Sleeve Cost
- •1.1 Economic Methodologies
- •1.2 Fixed Costs: Medical Devices
- •1.3 Fixed Costs: Personnel
- •1.4 Variable Costs: Reusable Instruments
- •1.5 Variable Costs: Disposables
- •2 Bariatric Surgery Costs
- •2.1 Methods for Identifying Cost Components
- •2.2 Methods for Valuing Cost Components
- •3 The Cost of the Sleeve Around the World
- •References
- •Analysis of LSG Competitors
- •1 Competition in the Industry
- •2 Potential of New Entrants into the Industry
- •3 Threat of Substitute Products
- •3.1 Anti-obesity Medications
- •3.2 Herbal and Alternative Medicine
- •3.3 Diet Program
- •3.4 Exercise
- •3.5 Acupuncture and Acupressure for Weight Loss
- •4 Power of Customers
- •5 Power of Suppliers
- •5.1 Strengths
- •5.2 Weaknesses
- •5.3 Weaknesses of Duodenal Switch Surgery
- •5.4 Opportunities
- •5.5 Threats
- •References
- •Medical Tourism: Global Bariatric Healthcare
- •1 Introduction
- •2 The Impetus Behind Global Healthcare
- •4 Conclusion
- •References
- •Sleeve Gastrectomy: Medicolegal Aspects
- •References
- •Laparoscopic Sleeve Gastrectomy 101
- •References
- •Robotic Sleeve Gastrectomy
- •1 Introduction
- •2 Robotic-Assisted Sleeve Gastrectomy
- •3 Cost of Robotic-Assisted Sleeve Gastrectomy
- •5 Operative Technique
- •6 Clinical Outcomes
- •7 Future Directions
- •8 Conclusion
- •References
- •Laparoscopic Sleeve Gastrectomy in Situs Inversus Totalis
- •1 Introduction
- •2 How to Perform the Procedure
- •3 Discussion
- •4 Conclusion
- •References
- •Banded Sleeves
- •1 Introduction
- •2 Procedure
- •3 Pre- Intra- and Post-Operative Management
- •4 Results
- •5 Band Complications
- •7 Conclusions
- •References
- •Buttressing the Sleeve
- •1 Introduction
- •2 Technical Aspects
- •3 Buttressing for Bleeding
- •4 Buttressing for Leaks
- •5 Results from the MBSAQIP
- •6 Previous Evidence
- •7 Conclusion
- •References
- •Sleeve and Ventral Hernias
- •1 Introduction
- •2 Prevalence, Incidence and Cost of Ventral Hernia
- •4 Primary Abdominal Wall Hernia
- •5 Incisional Hernia
- •5.1 Medial or Midline Zone
- •5.2 Lateral Hernias (Flank Hernias)
- •6 Size of the Hernia
- •7 Indication and Risks of Ventral Hernia Repair
- •8.1 Position of Trocar and Creation of Pneumoperitoneum
- •9 Principles of Adhesiolysis
- •10 Measurement of Hernia Defect
- •12 Technique of Open Ventral Hernia Repair [10, 25, 26]
- •13 Concurrent LSG with LVHR
- •14 LSG with Sequential LVHR
- •15 Conclusion
- •References
- •1 Introduction
- •5 Operative Concerns and Patient Selection
- •6 Preoperative Evaluation
- •7 Esophageal High-resolution Manometry
- •8 Surgical Technique
- •9 Discussion
- •References
- •Omentopexy in Laparoscopic Sleeve Gastrectomy
- •1 Background
- •3 Omentopexy in Sleeve Gastrectomy
- •3.2 Operative Technique
- •5 Effect on Gastric Emptying
- •6 Conclusion
- •References
- •Sleeve Gastrectomy and Gallstones Disease
- •1 Introduction
- •2 Obesity and the Risk of Gallstone
- •3 Rapid Weight Loss and the Risk of Gallstone
- •5 Incidence of Cholecystectomy in Sleeve Gastrectomy
- •6 Biliary Complications Post LSG
- •7 Cholecystectomy: When to Operate?
- •8 Prophylactic (Routine) Cholecystectomy
- •9 Elective (Selective) Cholecystectomy:
- •11 Ursodeoxycholic Acid (UDCA) Prophylaxis
- •12.1 Dose, Frequency
- •13 Disadvantages of UDCA
- •14 Summary
- •15 Conclusion
- •References
- •LSG Under Block Anesthesia (PVB)
- •1 Introduction
- •2 Review on General Anesthesia
- •2.1 General Overview
- •2.2 General Anesthesia in the Obese/bariatric Population
- •3 Review on Paravertebral Block (PVB)
- •4 Anatomy
- •4.1 Indication
- •4.2 Techniques
- •4.2.1 Blind Technique
- •4.2.2 Neurostimulation Technique
- •4.2.3 Ultrasound Guided Technique
- •4.3 Mechanism and Spread of Anesthetic
- •4.4 Anesthetic Drugs
- •4.5 Complications
- •4.6.1 Abdominal Surgeries
- •4.6.2 First Paravertebral Block in Sleeve Gastrectomy
- •References
- •Elderly High Risk Patients Undergoing Laparoscopic Sleeve Gastrectomy
- •1 Scope of the Problem
- •1.1 Increasing of the Elderly Population
- •1.3 Risks of Surgery in the Elderly
- •1.3.1 Bariatric Surgery in Elderly
- •2 Sleeve Gastrectomy: Procedure of Choice
- •2.1 Intraoperative Difference in Elderly
- •3 Postoperative Care in the Elderly
- •4 Postoperative Mortality and Morbidity
- •5 Postoperative Outcomes
- •5.1 Excess Body Weight Loss
- •5.2 Comorbidities Improvement
- •5.3 Quality of Life Improvement
- •6 LSG in Septuagenarians and Elderly Super Obese
- •7 LSG Compared to Gastric Bypass in Elderly
- •8 Conclusions
- •References
- •Postoperative Diet Progression for Laparoscopic Sleeve Gastrectomy
- •1 Introduction
- •2 Diet Progression: Stages
- •3 Conclusion
- •References
- •How Laparoscopic Sleeve Gastrectomy May Cause Weight Loss
- •1 Ghrelin Effect
- •1.1 Other Gastrointestinal Hormone Secretion
- •1.2 Other Molecular Changes
- •1.3 Bile Acid Metabolism
- •1.4 Microbiome
- •1.5 Central Nervous System Changes
- •1.6 Conclusion
- •References
- •Expected Weight Loss After the Sleeve
- •1 Introduction
- •2 Preoperative Weight Loss
- •3 Short-Term and Mid-Term Outcomes
- •4 Long-Term Outcomes
- •6 Summary
- •References
- •1 Introduction
- •2 Set Point Theory
- •3 Weight Regulation and Weight Loss Maintenance
- •6 Neurohormonal Regulation of the Body Set Point
- •8 Conclusions
- •References
- •Quality of Life and Bariatric Surgery
- •1 Medical Outcomes Survey Short Form 36S (SF-36)
- •3 The Bariatric Quality of Life Index (BQL)
- •References
- •LSG: Risks and Considerations
- •Risks Associated with Sleeve Gastrectomy
- •References
- •Outcomes and Complications After Sleeve Gastrectomy
- •1 Introduction
- •2 Impact on Obesity
- •3 Impact on Diabetes
- •4 Impact on Hypertension
- •5 Impact on Dyslipidaemia
- •6 Complications
- •7 Non-Surgical Complications of Sleeve Gastrectomy
- •9 Early Complications of Sleeve Gastrectomy
- •10 Alteration to Bile Flow After Sleeve Gastrectomy
- •11 Anatomical Changes After Sleeve Gastrectomy
- •12 Vagus Nerve Modulation After Sleeve Gastrectomy
- •13 Cardiovascular Effects of Sleeve Gastrectomy
- •14 Effects on Microbiota After Sleeve Gastrectomy
- •15 Impact on Metabolism After Bariatric Surgery
- •16 Conclusion
- •References
- •How to Manage Sleeve Complications: Hemorrhage
- •1 Background
- •2 Bleeding Cascade, Patient and Surgeon Factor
- •3 Surgical Stapler Technology
- •4 Management and Prevention
- •4.1 Buttressing, Oversewing
- •5 Hemostats
- •6 Summary
- •References
- •Endoscopic Management of Leak and Abscess Following Laparoscopic Sleeve Gastrectomy
- •1 Introduction
- •3 Closure of the Leak Site
- •3.1 Self-Expanding Metal Stents
- •3.2 Types of SEMS
- •3.3 SEMS Insertion Procedure
- •3.4 Outcome of SEMS Placement
- •3.5 Over-The Scope Clip System
- •4 Internal Drainage
- •4.1 Endoscopic Internal Drainage
- •4.2 EID Procedure
- •4.3 Outcome of EID Procedure
- •4.4 Endoscopic Vacuum Therapy
- •5 Septotomy and Pneumatic Balloon Dilatation
- •6 Conclusion
- •References
- •How to Manage Sleeve Complications: Surgical Leak and Abscess
- •1 Introduction
- •2 Principles of Management
- •3 Endoscopy
- •4 Surgery
- •4.1 Control of Early Complications and Nutritional Status
- •4.2 The Leak Site
- •4.3 Roux en Y Fistulo-Jejunostomy
- •4.4 Literature Review of the Remaining Surgical Options
- •4.5 Discussion of the Surgical Approach
- •5 Conclusion
- •References
- •How to Manage Sleeve Complications Through Endoscopy: Strictures
- •1 Introduction
- •4 Signs and Symptoms
- •5 Diagnosis and Management
- •6 Bougie Dilation
- •8 Self-Expanding Metal Stent (SEMS) Placement
- •10 Strategies for Endoscopic Success
- •11 Conclusions
- •References
- •Sleeve Gastrectomy Stenosis: Surgical Treatment
- •1 Introduction
- •2 Diagnosis
- •3 Incidence
- •4 Prevention
- •5 Treatment
- •6 Conclusion
- •References
- •1 Introduction
- •2 Mechanisms of GERD Post-Sleeve Gastrectomy
- •3 Incidence of GERD After Sleeve Gastrectomy
- •4 Screening Recommendations
- •5 Role of Pharmacotherapy, Diagnosis, and Testing
- •7 Radiofrequency Ablation
- •8 Transoral Incisionless Fundoplication (TIF)
- •9 Conclusion
- •References
- •1 Background
- •2 Pathophysiology

How to Manage Sleeve Complications: Surgical Leak and Abscess
Fig. 2 Anterior approach to the RYFJ: Adhesions between the left liver lobe and the sleeved
stomach are divided
467
Fig. 3 Mobilization of the esophagogastric junction: Both the left and the right arms of the diaphragmatic crura are identifible as well as a previously inserted pigtail drain (PTD)
It is not mandatory to close the mesocolon defect around the Roux limb.
Percutaneous closed drainage of the hiatal area is optional. No naso-gastric tube is
required.

E. Chouillard468
Fig. 4 Mobilization of the esophagogastric junction: The Angle of His is to be detached from
the left arm of the crura while making sure the left pleura is not teared
Fig. 5 The fistula site is now completely debrided with well-vascularized, healthy edges, ready
to be anastomosed to the jejunum

How to Manage Sleeve Complications: Surgical Leak and Abscess
Fig. 6 The closing stages of the side-to-side fistulo-jejunostomy using an absorbable runing
suture
469
In the postoperative period, patients had control CT scan with oral contrast
fluid at POD3 before resuming oral intake.
Between January 2007 and December 2018, we managed 221 patients with
SGL. Remission is defined as the absence of clinical or radiological expression of
the SGL site itself or by its consequences (i.e., collection, extravasation, air bubbles). Healing is nothing by a definite remission (i.e., apparent remission + absence
of recurrence). We made this distinction after noticing that apparently “healed”
SGL may recur even many years later (i.e., pregnancy, pancreatitis, malnutrition,
chronic illness) [27]. We could easily understand the situation if we compare a
SGL to type 2 diabetes mellitus. Its remission after bariatric surgery and weight
loss must not be confound with healing.
Of the initial 221 patients, 82 (37.1%) underwent eventually RYFJ. The median
age of SGL in the entire population of patients presenting for RYFJ was 5 months
(range, 0–133). The longest interval between the primary SG and the declaration of the SGL (during a pregnancy) was more than 10 years. In the subgroup
of patients who presented with less than 3-months SGL, the median interval was
16 days (range, 1–88).
Endoscopic treatment was attempted in almost all of the patients, including stenting, IED, clips, glue, sponge, or septotomy. The success rate of the first

E. Chouillard470
attempt at endoscopic treatment was 66.4%. In patients with more than one cycle
of endoscopic treatment, the remission rate rose eventually to 79.1%.
Laparoscopy was attempted in 96.4% of the patients, while 3 patients had
open surgery (i.e., the first 3 patients of the series in 2007). Secondary conversion to laparotomy occurred in only 2 patients (2.5%). The causes of conversion
were poor exposure and bleeding in both cases. The left lobe of the liver was the
major cause of poor exposure. The splenic vessels were the most common cause
of bleeding. The mean operative time was 200 minutes (100–450). Besides two
limited bleedings, no major operative incident was encountered. No splenectomy
had to be performed.
The mortality rate was nil. The post-operative rate of complications was 6.1%
with Only 2 patients had persistent post operative leak (24%). Both eventually
healed in less than 10 days with conservative management.
Long-term analysis of this series revealed that the 10-years control rate of the
SGL was 100% either endoscopic wise (Fig. 7) or as defined by radiology (Fig. 8).
Interestingly, the long-term analysis of the results revealed that the patients who
had RYFJ obtained better long-term weight loss results as compared to those who
had primary SG with no complications (Fig. 9).
4.4 Literature Review of the Remaining Surgical Options
Excluding our experience, less than 20 studies in the literature addressed series
with more than 5 patients who had some form of surgical treatment for patients
with SGL [28]. Almost 60% of these reported patients who had TG (inreality,
these were mainly open Total Degastro-Gastrectomy with Roux en Y Eso-Jejunal
anastomosis). Surprisingly, nearly 10% of authors performed Roux En Y Gastric
Bypass, even for high SGL.
Fig. 7 Illustrative endoscopic endoscopic view of the esophagogastirc junction in a patient who
had previous RYFJ, showing a double oulet pattern (i.e., jejunal and gastric) with no residual
fistula

How to Manage Sleeve Complications: Surgical Leak and Abscess
Fig. 8 Illustrative radiological, CT, coronal view of the upper abdomen in a patient who had previous RYFJ, showing a double oulet pattern (i.e., jejunal and gastroduodenal) with no residual fistula
471
Fig. 9 5-year, total weight loss pattern in patients who had RYFJ for leak after SG as compared
to matched patients who had non-complicated SG at the same period
The laparoscopic approach succeeded in less than 70% of cases with a conversion rate of 6.4% [28]. The most common complication reported for all types of
definitive reconstructive surgeries was another leak (15%), including 37.5% following RYGB, 30% other forms of fistula-jejunostomy, and 8% after TG. The

E. Chouillard472
healing time for a leak following definitive reconstructive surgeries varied between
10 and 165 days. Other complications were reported in 12.3% of patients, including included intra-abdominal abscesses, wound infection, pulmonary embolism,
intestinal obstruction, and miscellaneous other entities.
Mortality was reported in 1% of cases. However, we believe this is
under-estimated since patients may die from complications linked to the SGL
before surgery or more than 30 days after surgery, without being accounted for in
the overall rate.
4.5 Discussion of the Surgical Approach
SGL are more likely to occur in SG patients with distal stenosis, resulting in difficulties in gastric emptying [29]. High intraluminal pressure and low compliance of
the gastric tube may be entertaining causes of SGL [30]. This is why RYFJ seems
to be a pathophysiologically relevant solution since it bypasses both difficulties
(i.e., gastric lack of compliance and endo-luminal high pressure). Additionally,
RYFJ is a surgically conservative option requiring no organ removal (as compared to TG) while not leaving in situ the leak site (as compared to the majority of
RYGBs). However, additional factors are most probably implicated in the occurrence of SGL, including impaired suture line healing, poor blood flow, infection,
and poor oxygenation with subsequent ischemia. All of these items are addressed
either by the preoperative optimization of the patient’s nutritional status or the peroperative surgical debridement during the RYFJ.
Our experience was forged from a heterogeneous panel of techniques used in
SG since patients came from 8 different countries with as many different techniques. However, the management has been eventually homogeneous and implemented by the same multidisciplinary team. Our approach to the management
of SGL has evolved after nearly 15 years of experience with this technique. Our
first SG was performed in 2002 as a part of a duodenal switch and in 2004 as a
stand-alone procedure. Multidisciplinary approach is always indicated with decisions taken jointly by the surgeon, the gastroenterologist, the radiologist, the nutritionist, and the critical care specialist. The patient is closely monitored by a team
of psychologists specialized in obesity management. Depression and suicide ideas
are common among these patients who have been treated, for some of them, for
years with long cumulated hospital stays.
RYGB could still be an option in case of possible gastric remnant. However,
limitations include the risk of leaving the fistula tract in very high localization and
the metabolic consequences of the procedure. Moreover, numerous patients are
reluctant to the idea of having a RYGB. TG is associated to a relatively high risk
of complications related to both the esophagojejunal anastomosis and the duodenal stump. Moreover, the long term nutritional consequences are cumbersome with
malnutrition, weight loss, anemia and the need to readjust the volume and frequencies of meals.

How to Manage Sleeve Complications: Surgical Leak and Abscess
Fig. 10 A proposed algorithm for the management of leak after SG
473
We believe that RYFJ is the most adequate option since it controls the fistula
site in all cases, may preserve the chance of maintaining the SG preferential pathway in the future and avoid the complications of an anastomosis performed on an
ill-vascularized esophagus. The use of a Roux limb type for the anastomosis aims
to allow less tension on the gastrojejunal anastomosis while avoiding the risk of
biliary reflux. Finally, our recent results on long term control of weight loss in
patients with RYFJ are very encouraging.
5 Conclusion
In conclusion, we believe that RYFJ is a safe and confirmed treatment for patients
with persistent SGL. It may even be used as a first option in some patients with
acute SGL.
Figure 10 summarizes our algorithm of management of SGL.
References
1. Varela JE, Nguyen NT. Laparoscopic sleeve gastrectomy leads the US utilization of bariatric
surgery at academic medical centers. Surg Obes Relat Dis. 2015;11:987–90.
2. International Federation for the Surgery of Obesity and Metabolic Disorders website; https://
www.ifso.com/sleeve-gastrectomy/.
3. Gagner M, Kemmeter P. Comparison of laparoscopic sleeve gastrectomy leak rates in five
staple-line reinforcement options: a systematic review. Surg Endosc. 2020;34:396–407.

E. Chouillard474
4. Cesana G, Cioffi S, Giorgia R, et al. Proximal leakage after laparoscopic sleeve gastrectomy:
an analysis of preoperative and operative predictors on 1738 consecutive procedures. Obes
Surg. 2018;28:627–35.
5. D’Ugo S, Gentileschi P, Benavoli D, et al. Comparative use of different techniques for leak
and bleeding prevention during laparoscopic sleeve gastrectomy: a multicenter study. Surg
Obes Relat Dis. 2014;10:450–4.
6. Berger ER, Clements RH, Morton JM, et al. The impact of different surgical techniques
on outcomes in laparoscopic sleeve gastrectomies: the first report from the metabolic and
bariatric surgery accreditation and quality improvement program (MBSAQIP). Ann Surg.
2016;264:464–73.
7. Varban OA, Sheetz KH, Cassidy RB, et al. Evaluating the effect of operative technique
on leaks after laparoscopic sleeve gastrectomy: a case-control study. Surg Obes Relat Dis.
2017;13:560–7.
8. Birkmeyer JD, Finks JF, O’Reilly A, et al. Surgical skill and complication rates after bariatric
surgery. N Engl J Med. 2013;369:1434–42.
9. Hany M, Ibrahim M. Comparison between stable line reinforcement by barbed suture and
non-reinforcement in sleeve gastrectomy: a randomized prospective controlled study. Obes
Surg. 2018;28:2157–64.
10. Wang H, Lu J, JFeng J, Z Wang Z. Staple line oversewing during laparoscopic sleeve gas-
trectomy. Ann R Coll Surg Engl. 2017;99:509–14.
11. Hughes D, Hughes I, Khanna A. Management of staple line leaks following sleeve gastrec-
tomy: a systemic review. Obes Surg. 2019;29:2759–72.
12. Nedelcu M, Manos T, Gagner M, Eddbali I, Ahmed A, Noel P. Cost analysis of leak after
sleeve gastrectomy. Surg Endosc. 2017;31:4446–50.
13. Peel AL, Taylor EW. Proposed definitions for the audit of 26 postoperative infections: a dis-
cussion paper. Surgical Infection Study Group. Ann R Coll Surg Engl. 1991;73:385–8.
14. Csendes A, Burdiles P, Burgos AM, Maluenda F, Diaz JC. Conservative management of
anastomotic leaks after 557 open gastric bypasses. Obes Surg. 2005;15:1252–6.
15. Welsch T, von Frankenberg M, Schmidt J, Büchler MW. Diagnosis and definition of anasto-
motic leakage from the surgeon’s perspective. Chirurg. 2011;82:48–55.
16. Rogalski P, Swidnicka-Siergiejko A, Wasielica-Berger J, et al. Endoscopic management of
leaks and fistulas after bariatric surgery: a systematic review and meta-analysis. Surg Endosc.
2020. https://doi.org/10.1007/s00464-020-07471-1. Epub ahead of print. PMID: 32107632.
17. Chahine E, D’Alessandro A, Elhajjam M, et al. Massive gastrointestinal bleeding due to
splenic artery erosion by a pigtail drain in a post sleeve gastrectomy leak: a case report. Obes
Surg. 2019;29:1653–6.
18. Siddique I, Alazmi W, Al-Sabah SK. Endoscopic internal drainage by double pigtail stents
in the management of laparoscopic sleeve gastrectomy leaks. Surg Obes Relat Dis. 2020.
https://doi.org/10.1016/j.soard.2020.03.028.
19. El Kary N, Chahine E, Moryoussef F, et al. Esophageal stricture due to a self-expandable
metal stent (SEMS) placement for post sleeve gastrectomy leak: a case report. Obes Surg.
2019;29:1943–5.
20. Puli SR, Spofford IS, Thompson CC. Use of self-expandable stents in the treatment of
bariatric surgery leaks: a systematic review and meta-analysis. Gastrointest Endosc.
2012;75:287–93.
21. Okazaki O, Bernardo WM, Brunaldi VO, et al. Efficacy and safety of stents in the treat-
ment of fistula after bariatric surgery: a systematic review and meta-analysis. Obes Surg.
2018;28:1788–96.
22. Chouillard E, Younan A, Alkandari M, et al. Roux-en-Y Fistulo-Jejunostomy as a salvage
procedure in patients with post-sleeve gastrectomy fistula: mid-term results. Surg Endosc.
2016;304200–4.
23. Chouillard E, Chahine E, Schoucair N, et al. Roux-En-Y Fistulo-Jejunostomy as a salvage
procedure in patients with post-sleeve gastrectomy fistula. Surg Endosc. 2014;28:1954–60.

How to Manage Sleeve Complications: Surgical Leak and Abscess
24. Chouillard E, Chahine E, D’Alessandro A, Vitte RL, Gumbs A, Kassir R. Roux-en-Y Gastro-
Jejunostomy for complex leak after the “Nissen” variant of sleeve gastrectomy. Obes Surg.
2020. https://doi.org/10.1007/s11695-020-04731-w.
25. Chour M, Alami RS, Sleilaty F, Wakim R. The early use of Roux limb as surgical treatment
for proximal postsleeve gastrectomy leaks. Surg Obes Relat Dis. 2014;10:106–10.
26. Bruzzi M, Douard R, Voron T, Berger A, Zinzindohoue F, Chevallier JM. Open total gas-
trectomy with Roux-en-Y reconstruction for a chronic fistula after sleeve gastrectomy. Surg
Obes Relat Dis. 2016;12:1803–8.
27. Zanotti D, Elkalaawy M, Mohammadi B, Hashemi M, Jenkinson A, Adamo M.
Gastro-cutaneous fistula 4 years after a fully resolved staple line leak in sleeve gastrectomy.
J Surg Case Rep. 2015;12:rjv152. https://doi.org/10.1093/jscr/rjv152. PMID: 26654903;
PMCID: PMC4674533.
28. Nedelcu M, Danan M, Noel P, Gagner M, Nedelcu A, Carandina S. Surgical management
for chronic leak following sleeve gastrectomy: review of literature. Surg Obes Relat Dis.
2019;15:1844–9.
29. Yehoshua RT, Eidelman LA, Stein M, et al. Laparoscopic sleeve gastrectomy–volume and
pressure assessment. Obes Surg. 2008;18:1083–8.
30. Baltasar A, Bou R, Bengochea M, Serra C, Cipagauta L. Use of a Roux Limb to correct
esophagogastric junction fistulas after sleeve gastrectomy. Obes Surg. 2007;17:1408–10.
475

How to Manage Sleeve Complications Through Endoscopy: Strictures
Thomas R. McCarty and Christopher C. Thompson
1 Introduction
As the total number of individuals within the United States and worldwide with
obesity has continued to increase over the past several decades, so too has the
use of bariatric surgery [1–3]. As of 2013, laparoscopic sleeve gastrectomy has
become the most common type of bariatric surgery performed in the United
States, accounting for more than 50% of all bariatric procedures at this time [4–
7]. Although this increase in the number of laparoscopic sleeve gastrectomy pro-
cedures reflects several advantages over alternative bariatric surgeries, namely a
reduced number of complications with lower morbidity compared to traditional
Roux-en-Y gastric bypass, sleeve-related leaks, de novo gastroesophageal reflux
disease (GERD), and sleeve-associated stenosis may occur [8–10]. In this review,
we will discuss proper identification, classification, and endoscopic management
of sleeve stenosis.
2 Timing, Classification, and Rate of Sleeve Stenosis
While sleeve gastrectomy-related leaks and GERD typically occur early and late
in the post-operative course, respectively, sleeve stenosis and stricture formation may occur are any time post-surgery. After sleeve leaks, stenosis is the most
T. R. McCarty · C. C. Thompson (*)
Brigham and Women’s Hospital, Boston, USA
e-mail: CCTHOMPSON@bwh.harvard.edu
T. R. McCarty
e-mail: trmccarty@bwh.harvard.edu
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer
Nature Switzerland AG 2021
S. Al-Sabah et al. (eds.), Laparoscopic Sleeve Gastrectomy,
https://doi.org/10.1007/978-3-030-57373-7_45
477
Соседние файлы в папке Библиотека им академика М.И. Перельмана
